Answers are grounded in this paper and cite their sources.
Sleep plays a crucial biological role and is responsible for overall well-being. Poor sleep is associated with several negative health conditions. Sleep fragmentation and chronic intermittent hypoxia in patients with obstructive sleep apnea can lead to several negative health effects, including a collection of metabolic disorders known as “metabolic syndrome,” which includes the development of non-alcoholic fatty liver disease. Decreased O2 at the tissue level leads to the development of adaptive mechanisms, including hypoxia-induced signalling as hypoxia-inducible factors, stress responses as endoplasmic reticulum stress, and autophagy by reactive oxygen species. In addition to this, disrupted gut barrier integrity, increased gut permeability, dyslipidemia, and insulin resistance have a pathologic role in non-alcoholic fatty liver disease development. The prognosis of non-alcoholic fatty liver disease in obstructive sleep apnea is a multifactorial process. Our review will clarify the complex and multifactorial pathophysiological mechanisms that contribute to the development of non-alcoholic fatty liver disease in patients with obstructive sleep apnea, as well as how the condition may progress to non-alcoholic steatohepatitis.
No takes yet. Share an insight, caveat, or question.
Dongol et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: